Published in Women's Health Weekly, April 14th, 2005
This purpose of the study "was to introduce Uniject (a new disposable device for administration of 10 IU oxytocin) as part of active management of the third stage of labor (AMTL) and try to reduce PPH," wrote R.T. Strand and colleagues.
"Postpartum hemorrhage is the single most common cause of maternal death in the world, and oxytocin is known to be effective for its prevention and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly